Fibrosis as measured by the biomarker, tissue inhibitor metalloproteinase-1, predicts mortality in Age Gene Environment Susceptibility-Reykjavik (AGES-Reykjavik) Study
European Heart Journal Sep 02, 2017
LaRocca G, et al. – Researchers presumed tissue inhibitor metalloproteinase–1 and matrix metalloproteinase–9 (TIMP–1 and MMP–9) as predictors of all–cause mortality and they evaluated the incremental value of these biomarkers when adjusting for clinical and other biomarkers. They reported that TIMP–1 most strongly predicted all–cause mortality after age. Findings also underscored the possible pathological relevance as well as prognostic significance of the metabolic pathways regulating extracellular matrix homeostasis and fibrogenic processes.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries